Tatiana Eidus, biophysicist by training, has over a decade of experience in clinical development. Holding positions at CROs and global pharma companies, Tatiana has accumulated wide expertise in operational aspects of initiating and managing Phase I-III trials across Europe and US. Drawn by ARENSIA’s team spirit and its mission to accelerate drug development process and enable patient´s access to novel medicines faster, Tatiana joined ARENSIA’s US office in Cambridge, MA in 2015. In her current role as Director Corporate Development, Tatiana is responsible for cross-functional coordination of setting up of new clinical programs and overseeing the trials throughout their execution. In her presentation Tatiana will be glad to share ARENSIA’s experience in the unique development process of COVID-19 therapies and will discuss the team’s views on impact of these experiences on future clinical research projects.